ERCC5
protein-codingERCC excision repair 5, endonuclease, the group of ERCC excision repair associated|Xeroderma pigmentosum complementation groups
Gene summary
This gene encodes a single-strand specific DNA endonuclease that makes the 3' incision in DNA excision repair following UV-induced damage. The protein may also function in other cellular processes, including RNA polymerase II transcription, and transcription-coupled DNA repair. Mutations in this gene cause xeroderma pigmentosum complementation group G (XP-G), which is also referred to as xeroderma pigmentosum VII (XP7), a skin disorder characterized by hypersensitivity to UV light and increased susceptibility for skin cancer development following UV exposure. Some patients also develop Cockayne syndrome, which is characterized by severe growth defects, cognitive disability, and cachexia. Read-through transcription exists between this gene and the neighboring upstream BIVM (basic, immunoglobulin-like variable motif containing) gene. [provided by RefSeq, Feb 2011]
- ERCM2
- XPGC
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~30.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0010216
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014696
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0010216
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0010216
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0019600
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0016354
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010216
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014696
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0010216
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0010216
Submitter: ClinGen
There is abundant evidence published associating the ERCC5 gene with xeroderma pigmentosum group G since the gene-disease relationship was first proposed by Nouspikel and Clarkson (1994). Multiple case level studies have been performed with XPG patients that have variants in the ERCC5 gene. 8 complementation groups genes (XPA, XPB, XPC, XPD, XPE, XPF, XPG, and XP variant (XPV)) in Nucleotide excision repair (NER) pathway were reported to cause Xeroderma Pigmentosum. Multiple xpg deficient mouse models have been established to show consistent phenotypes with XPG patients, including growth retardation, short life span and highly sensitive to UV light. All of these types of All of these types of evidence are consistent with a definitive relationship between the ERCC5 gene and xeroderma pigmentosum group G.
Inheritance Pattern: AR
Disease ID:MONDO:0008926
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic
Intervention: Dermatologic; Oncologic
Rationale: Skin lesions can be treated (and possibly prevented in some cases) with a variety of methods, depending on the specific type of lesion; Sun/UV exposure (and other agents, such as tobacco smoke) should be avoided; Periodic surveillance for dermatologic manifestations can be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ERCC5 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000123.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 121 | 4 | 132 | ||
| missense | 4 | 12 | 173 | 37 | 3 | 229 |
| nonsense | 11 | 10 | 1 | 22 | ||
| start loss | 0 | |||||
| frameshift | 20 | 20 | 5 | 45 | ||
| splice donor/acceptor (+/-2bp) | 1 | 6 | 7 | |||
| Total | 36 | 48 | 186 | 158 | 7 | 435 |
Highest pathogenic variant AF is 0.00006260941
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000114.3 | 15 | MANE Select | |
| Ensembl | ENSP00000498881.2 | 15 | MANE Select | |
| Ensembl | ENSP00000436083.1 | 3 | Standard | |
| Ensembl | ENSP00000498809.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Nucleotide excision repair - Homo sapiens (human)
- Nucleotide Excision Repair
- DNA Repair
- Formation of Incision Complex in GG-NER
- Dual Incision in GG-NER
Biological Process
- transcription-coupled nucleotide-excision repair
- nucleotide-excision repair
- nucleotide-excision repair, preincision complex stabilization
- nucleotide-excision repair, preincision complex assembly
- nucleotide-excision repair, DNA incision, 3'-to lesion
Molecular Function
- bubble DNA binding
- RNA polymerase II complex binding
- double-stranded DNA binding
- single-stranded DNA binding
- endodeoxyribonuclease activity
Cellular Component
- nucleotide-excision repair complex
- nucleus
- nucleoplasm
- DNA replication factor A complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000355739
- Coding exons
- 15
- Length
- 31152
- Individuals with no LoFs
- 125698
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 50
- Defined
- 125748
- p
- 0.000199
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.118 | 628 | 636 | 0.987 | 0.0000359 | 7798 |
| Missense (PolyPhen) | 220 | 225 | 0.97779 | 2766 | ||
| Synonymous | -0.151 | 251 | 248 | 1.01 | 0.0000157 | 2258 |
| Loss of Function | 2.64 | 28 | 47.7 | 0.587 | 0.00000243 | 580 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00017 | 0.00017 | rare |
| South Asian | 0.00062 | 0.00062 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Single-stranded structure-specific DNA endonuclease involved in DNA excision repair. Makes the 3'incision in DNA nucleotide excision repair (NER). Acts as a cofactor for a DNA glycosylase that removes oxidized pyrimidines from DNA. May also be involved in transcription-coupled repair of this kind of damage, in transcription by RNA polymerase II, and perhaps in other processes too.;
- Disease
- DISEASE: Xeroderma pigmentosum complementation group G (XP-G) [MIM:278780]: An autosomal recessive pigmentary skin disorder characterized by solar hypersensitivity of the skin, high predisposition for developing cancers on areas exposed to sunlight and, in some cases, neurological abnormalities. The skin develops marked freckling and other pigmentation abnormalities. Some XP-G patients present features of Cockayne syndrome, cachectic dwarfism, pigmentary retinopathy, ataxia, decreased nerve conduction velocities. The phenotype combining xeroderma pigmentosum and Cockayne syndrome traits is referred to as XP-CS complex. {ECO:0000269|PubMed:10447254, ECO:0000269|PubMed:11228268, ECO:0000269|PubMed:11841555, ECO:0000269|PubMed:12060391, ECO:0000269|PubMed:23255472, ECO:0000269|PubMed:7951246, ECO:0000269|PubMed:9096355}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cerebro-oculo-facio-skeletal syndrome 3 (COFS3) [MIM:616570]: A disorder of prenatal onset characterized by microcephaly, congenital cataracts, facial dysmorphism, neurogenic arthrogryposis, growth failure and severe psychomotor retardation. COFS is considered to be part of the nucleotide-excision repair disorders spectrum that include also xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome. {ECO:0000269|PubMed:24700531}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.493
Intolerance Scores
- LoFtool
- 0.898
- RVIS EVS
- 0.55
- RVIS percentile EVS
- 81.13
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.843
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |